Angioimmunoblastic T-cell lymphoma, in remission
- C86.51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- ICD-10-CM C86.51 is a new 2025 ICD-10-CM code that became effective on October 1, 2024.
- This is the American ICD-10-CM version of C86.51 – other international versions of ICD-10 C86.51 may differ.
Applicable To
- Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), in remission
The following code(s) above C86.51 contain annotation back-references
that may be applicable to C86.51:
- C00-D49 Neoplasms
- C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
- C86 Other specified types of T/NK-cell lymphoma
- C86.5 Angioimmunoblastic T-cell lymphoma
ICD-10-CM C86.51 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
- 974 Hiv with major related condition with mcc
- 975 Hiv with major related condition with cc
- 976 Hiv with major related condition without cc/mcc
Code History
- 2025 (effective 10/1/2024): New code